Review reveals potential predictors of long-term distress after cancer diagnosis

January 10, 2018, Wiley

A new review of published studies indicates that distress and neuroticism at or within 3 months of cancer diagnosis may predict emotional distress at least 12 months later. In the Psycho-Oncology analysis, there was no consistent evidence that demographic, clinical, or social factors reliably predict long-term distress.

The investigators noted that studies included in the analysis were varied, with different populations and methods. Therefore, additional studies are needed to test and expand the preliminary findings before any conclusions can be reached.

"While the research suggests that levels of distress and neuroticism around the time of diagnosis are useful markers of vulnerability, further prospective research is now needed in order to understand how these variables might be related and to identify the psychological mechanisms by which distress is maintained," said lead author Dr. Sharon Cook, of the University of Liverpool, in the UK.

Explore further: Cancer distress may lead to missed appointments

More information: Psycho-Oncology (2018). DOI: 10.1002/pon.4601

Related Stories

Cancer distress may lead to missed appointments

September 25, 2017
(HealthDay)—Seriously distressed cancer patients appear to miss more appointments and have more hospital admissions during treatment, a new study finds.

Many young cancer patients do not receive adequate fertility information and support

August 21, 2017
All cancer patients of reproductive age should be provided with fertility information and referrals for fertility preservation. A new Psycho-Oncology analysis of the published literature indicates that many cancer patients ...

Educational session helps alleviate distress in prostate cancer patients and their partners

May 19, 2017
In a recent study, an educational session helped alleviate distress equally in both patients with prostate cancer and their partners.

Diabetes-related distress ups risk for rx nonadherence

October 31, 2016
(HealthDay)—Diabetes-related distress and depression symptom severity are risk factors for medication nonadherence in type 2 diabetes, according to a study published online Oct. 17 in Diabetes Care.

Patients undergoing lung cancer screening experience elevated levels of distress

October 19, 2015
Low-dose computed tomography (LDCT) lung cancer screening is recommended to screen patients with an increased risk of developing lung cancer, but little research regarding the emotional toll of screening has been conducted. ...

Lower socioeconomic status is linked to obesity through distress and emotional eating

May 18, 2017
New research presented at this year's European Congress on Obesity in Porto, Portugal (17-20 May) shows that lower socioeconomic status is associated with higher body-mass index (BMI) through its effects on distress and subsequent ...

Recommended for you

New breath and urine tests detect early breast cancer more accurately

April 25, 2018
A new method for early and accurate breast cancer screening has been developed by researchers at Ben-Gurion University of the Negev and Soroka University Medical Center, using commercially available technology.

Do prostate cancer cells have an Achilles' heel?

April 25, 2018
Researchers at the University of Illinois at Chicago describe new ways to selectively kill prostate cancer cells by exploiting the cells' revved-up metabolism. They report their findings in the online journal, eLife.

Research shows possible new target for immunotherapy for solid tumors

April 24, 2018
Research from the University of Cincinnati (UC) reveals a potential new target to help T cells (white blood cells) infiltrate certain solid tumors.

Changes in breast tissue increase cancer risk for older women

April 24, 2018
Researchers in Norway, Switzerland, and the United States have identified age-related differences in breast tissue that contribute to older women's increased risk of developing breast cancer. The findings, published April ...

Targeting molecules called miR-200s and ADAR2 could prevent tumor metastasis in patients with colorectal cancer

April 24, 2018
Colorectal cancer is the third most common cancer worldwide and the third-leading cause of cancer-related deaths. The main cause of death in patients with colorectal cancer is liver metastasis, with nearly 70% of patients ...

Experimental arthritis drug prevents stem cell transplant complication

April 24, 2018
An investigational drug in clinical trials for rheumatoid arthritis prevents a common, life-threatening side effect of stem cell transplants, new research from Washington University School of Medicine in St. Louis shows. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.